Acino International AG
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Acino International AG
Celltrion has bought a portfolio of selected products in the Asia-Pacific region from Takeda, marking a foray into small-molecule drugs.
In continuing strategy to shed non-core assets globally, Japanese firm will sell portfolio of selected products in Asia-Pacific to Korean biosimilars giant Celltrion.
Danish firm picks up portfolio and manufacturing sites, along with around 600 employees.
Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.
- Contract Research, Toxicology Testing-CRO
- Generic Drugs
- OTC, Consumer
- Controlled Release
- Other Names / Subsidiaries
- Acino Holding AG